Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration

NCT00556348 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: bevacizumab

Sponsor

Instituto de Olhos de Goiania